Page last updated: 2024-11-05

trypan blue

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

VisionBlue: A trypan blue ophthalmic solution. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Trypan Blue: A diazo-naphthalene sulfonate that is widely used as a stain. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

trypan blue : An organosulfonate salt that is the tetrasodium salt of 3,3'-[(3,3'-dimethylbiphenyl-4,4'-diyl)didiazene-2,1-diyl]bis(5-amino-4-hydroxynaphthalene-2,7-disulfonic acid). [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6296
CHEMBL ID177987
CHEMBL ID1640
CHEBI ID78897
MeSH IDM0022059
PubMed CID135421783
MeSH IDM0022059

Synonyms (153)

Synonym
diamine blue
c.i. direct blue 14, tetrasodium salt
sodium ditolyldisazobis-8-amino-1-naphthol-3,6-disulfonate
c.i. 23850
nsc-11247
c.i. direct blue 14
congo blue
benzamine blue
niagara blue
dianil blue
benzo blue
naphthylamine blue
ai3-26698
trypan (congo) blue
2,7-naphthalenedisulfonic acid, 3,3'-((3,3'-dimethyl(1,1'-biphenyl)-4,4'-diyl)bis(azo))bis(5-amino-4-hydroxy-, tetrasodium salt
einecs 200-786-7
modr prima 14 [czech]
tetrasodium 3,3'-((3,3'-dimethyl(1,1'-biphenyl)-4,4'-diyl)bis(azo))bis(5-amino-4-hydroxynaphthalene-2,7-disulphonate)
vision blue
modr trypanova [czech]
visionblue
ccris 616
trypan blue (commercial grade)
nci c61289
sodium ditolyldisazobis-8-amino-1-naphthol-3,6-disulphonate
rcra waste no. u236
azidinblau 3b
diaminine blue
trypanblau [german]
rcra waste number u236
nsc 11247
direct blue 14
sodium ditolyl-diazobis-8-amino-1-naphthol-3,6-disulfonate
hsdb 2945
tetrasodium 3,3'-((3,3'-dimethyl(1,1'-biphenyl)-4,4'-diyl)bis(azo))bis(5-amino-4-hydroxynaphthalene-2,7-disulphonate
FT-0690008
CHEMBL177987
T0556
CHEMBL1640
chebi:78897 ,
membraneblue
unii-i2zwo3ls3m
modr prima 14
2,7-naphthalenedisulfonic acid, 3,3'-((3,3'-dimethyl(1,1'-biphenyl)-4,4'-diyl)bis(2,1-diazenediyl))bis(5-amino-4-hydroxy-, sodium salt (1:4)
modr trypanova
i2zwo3ls3m ,
C19307
dtxsid4026268 ,
dtxcid006268
tox21_112549
cas-72-57-1
trypan blue [iarc]
tetrasodium 3,3'-((3,3'-dimethyl-4,4'-biphenylene)bis(azo))bis(5-amino-4-hydroxy-2,7-naphthalenedisulphonate)
trypan blue [hsdb]
3,3'-((3,3'-dimethyl(1,1'-biphenyl)-4,4'-diyl)bis(azo))bis-(5-amino-4-hydroxy)-2,7-naphthalenedisulfonic acid tetrasodium salt
sodium ditolyl-diazobis-8-amino-1-naphthol-3,6-disulphonate
3,3'-((3,3'-dimethyl-4,4'-biphenylene)bis(azo))bis(5-amino-4-hydroxy-2,7-naphthalenedisulfonic acid) tetrasodium salt
trypan blue [mart.]
trypan blue [vandf]
trypan blue [mi]
trypan blue [orange book]
trypan blue [who-dd]
tetrasodium 3,3'-((3,3'-dimethyl-4,4'-biphenylene)bis(azo))bis(5-amino-4-hydroxy-2,7-naphthalenedisulfonate)
AKOS015902434
tetrasodium 3,3'-[(3,3'-dimethylbiphenyl-4,4'-diyl)didiazene-2,1-diyl]bis(5-amino-4-hydroxynaphthalene-2,7-disulfonate)
directblue14
mfcd00003969
trypan blue, dye content 60%
AKOS030228627
trypan-blue
diphenyl blue
sodium 3,3'-(1e,1'e)-(3,3'-dimethylbiphenyl-4,4'-diyl)bis(diazene-2,1-diyl)bis(5-amino-4-hydroxynaphthalene-2,7-disulfonate)
sodium 3,3'-((3,3'-dimethyl-[1,1'-biphenyl]-4,4'-diyl)bis(diazene-2,1-diyl))bis(5-amino-4-hydroxynaphthalene-2,7-disulfonate)
AMY22430
2,7-naphthalenedisulfonic acid,3,3'-[(3,3'-dimethyl[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[5-amino-4-hydroxy-, tetrasodium salt
AS-83614
bleu trypan
azul tripano
SY077059
trypan blue sodium salt
wln: l66j bq dswq hswq jz cnunr b d- 2 &-na- 4
trypanblau
2, 3,3'-[(3,3'-dimethyl-4,4'-biphenylylene)bis(azo)]bis(5-amino-4-hydroxy-, tetrasodium salt
benzo blue 3bs
2, 3,3'-[(3,3'-dimethyl[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[5-amino-4-hydroxy-, tetrasodium salt
bleu trypane n
directakol blue 3bl
72-57-1
amidine blue 4b
chlorazol blue 3b
benzanil blue r
blue 3b
chloramiblau 3b
pyrotropblau
chloramine blue
blue emb
diphenyl blue 3b
tripan blue
diaphtamine blue th
orion blue 3b
amanil sky blue r
paramine blue 3b
congoblau 3b
trianol direct blue 3b
azidine blue 3b
naphtamine blue 3bx
dianilblau h3g
niagara blue 3b
bleu diazole n 3b
benzanil blue 3bn
trypan blue
direct blue h3g
direct blue m3b
direct blue 3b
naphthamine blue 3bx
diazine blue 3b
dianil blue h3g
parkipan
pyrazol blue 3b
triazolblau 3bx
congo blue 3b
azurro diretto 3b
diaminblau 3b
diamine blue 3b
dianilblau
brasilazina blue 3b
renolblau 3b
benzamine blue 3b
naphthaminblau 3bx
parkibleu
nsc11247
chrome leather blue 3b
chloramine blue 3b
bencidal blue 3b
cresotine blue 3b
azirdinblau 3b
bleu directe 3b
direct blue d3b
trypan blue bpc
directblau 3b
trypane blue
bleu diamine
direct blue 3bx
brasilamina blue 3b
diamineblue
diazol blue 3b
benzo blue 3b
hispamin blue 3bx
benzaminblau 3b
benzoblau 3b
bleue diretto 3b
centraline blue 3b
pontamine blue 3bx

Research Excerpts

Toxicity

Trypan blue is safe in a cell culture model. Phacoemulsification using trypan blue was safe and effective in managing white cataract and had a high success rate.

ExcerptReferenceRelevance
" Prenatal toxic action of the pesticides used today may be detrimental to human and animal health."( [Studies on the prenatally toxic effect of parathionemethyl in Wistar rats compared to cyclophosphamide and trypan blue].
Fuchs, V; Golbs, S; Kühnert, M; Osswald, F, 1976
)
0.26
" A broad spectrum of model toxic compounds was evaluated for toxicity on mouse skin JB6 cells in culture."( Studies of skin toxicity in vitro: dose-response studies on JB6 cells.
Berezesky, IK; Fitzpatrick, MJ; Jain, PT; Phelps, PC; Trump, BF, 1992
)
0.28
" The ability to isolate and maintain these cells in short term primary tissue culture has permitted us to develop an in vitro cytotoxicity assay for the study of these cells as potential targets to a variety of toxic stimuli."( A 51Cr release cytotoxicity assay for use with human intrahepatic biliary epithelial cells.
Ayres, RC; Coleman, R; Mills, CO; Neuberger, JM; Shaw, J, 1991
)
0.28
" Albumin slightly reduced the toxic effects, whereas the addition of zinc in various forms strongly inhibited these toxic effects of DHAA in the concentration range 10-500 micrograms/mL."( Neutralizing effect of zinc oxide on dehydroabietic acid-induced toxicity on human polymorphonuclear leukocytes.
Hallmans, G; Hänström, L; Holm, SE; Reuterving, CO; Söderberg, TA; Sunzel, B, 1991
)
0.28
" N-Acetyl-m-aminophenol (AMAP) was approximately 10-fold less toxic than APAP, despite the fact that it bound covalently to a greater extent to hepatocyte macromolecules."( Comparative cytotoxic effects of acetaminophen (N-acetyl-p-aminophenol), a non-hepatotoxic regioisomer acetyl-m-aminophenol and their postulated reactive hydroquinone and quinone metabolites in monolayer cultures of mouse hepatocytes.
Bjørge, C; Holme, JA; Hongslo, JK; Nelson, SD, 1991
)
0.28
" One hundred to 300 microM was toxic for all cell types, and concentrations above 300 microM resulted in fixation."( Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture.
Hefti, F; Michel, PP, 1990
)
0.28
" This study shows that despite the weakening of hepatocyte defense mechanisms by hypoxia, styrene is not acutely toxic to these cells."( Toxicity of styrene vapor in hepatocyte monolayers at low oxygen tensions.
Costa, AK; Trudell, JR, 1990
)
0.28
" The results confirm an earlier observation of limited antitumour activity of noxythiolin solutions and, on the basis of differential cytotoxicity, confirm that noxythiolin is free from adverse effects against normal tissues and is safe for use as an antimicrobial agent applied to peritoneal surfaces and the healing wound."( The differential cytotoxicity of antiseptic agents.
Blenkharn, JI, 1987
)
0.27
" Pretreatment of the mice by inducers of drug-metabolizing enzymes, such as 3-methylcholanthrene and Aroclor 1254, lowered the concentration threshold for the toxic responses."( Species differences in cytotoxic and genotoxic effects of phenacetin and paracetamol in primary monolayer cultures of hepatocytes.
Holme, JA; Søderlund, E, 1986
)
0.27
" Both types of conjugates caused considerable toxicity: allyl isothiocyanate conjugates gave effects comparable to the parent compound, but benzyl isothiocyanate was more toxic than its conjugates."( Glutathione- and cysteine-mediated cytotoxicity of allyl and benzyl isothiocyanate.
Bruggeman, IM; Temmink, JH; van Bladeren, PJ, 1986
)
0.27
" Therefore, the possible toxic effects of metals on the lung are of environmental and occupational concern."( Toxicity of metallic ions in the lung: effects on alveolar macrophages and alveolar type II cells.
Bowman, L; Castranova, V; Colby, H; Miles, PR; Wright, JR, 1984
)
0.27
"The toxic effects of 6-hydroxydopamine on the human neuroblastoma cell line SK-N-SH-SY5Y(SY5Y) and the Chinese hamster ovary (CHO) cell line were measured with five viability assays."( Evaluation of methods for determining 6-hydroxydopamine cytotoxicity.
Perez-Polo, JR; Tiffany-Castiglioni, E, 1980
)
0.26
" These data suggest that FK506 is reversibly and mildly toxic to monolayers of human renal proximal tubule cells and are consistent with clinical reports of reversible nephrotoxicity."( Cytotoxic effects of FK506 on human renal proximal tubule cells in culture.
Atcherson, MM; Trifillis, AL, 1994
)
0.29
" L-DOPA was toxic for both DA and non-DA neurons."( Toxic effects of L-DOPA on mesencephalic cell cultures: protection with antioxidants.
Casarejos, MJ; De Yébenes, JG; Mena, MA; Paíno, CL; Pardo, B, 1995
)
0.29
" The LD50 value of selenite was about 500 microM."( Toxicity, metabolism and absorption of selenite by isolated rat hepatocytes.
Park, YC; Whanger, PD, 1995
)
0.29
"Serum drawn from patients during clozapine-induced agranulocytosis was toxic to human polymorphonuclear leukocytes (PMNs)."( 51Cr release assay of clozapine-induced cytotoxicity: evidence for immunogenic mechanism.
Konings, SA; Pisciotta, AV, 1994
)
0.29
" Also, cell morphology showed early toxic changes, such as cytoplasmic vacuolization and cell shrinking, and it should be included with such toxicity evaluations."( Comparison of cell proliferation and toxicity assays using two cationic liposomes.
Jääskeläinen, I; Lappalainen, K; Syrjänen, K; Syrjänen, S; Urtti, A, 1994
)
0.29
" The toxicity of BHTOOH was potentiated by glutathione depletion and inhibited by thiol compounds, indicating that BHTOOH is activated to a thiol-reactive, toxic intermediate."( Role of quinone methide in the in vitro toxicity of the skin tumor promoter butylated hydroxytoluene hydroperoxide.
Guyton, KZ; Kensler, TW; Thompson, JA,
)
0.13
" The stress reactions measured in terms of significant changes in HSP synthesis and proteinase activity provide information about the mechanisms by which toxic agents act on the cell."( Heat shock response and cytotoxicity in C6 rat glioma cells: structure-activity relationship of different alcohols.
Fracella, F; Neuhaus-Steinmetz, U; Oberheitmann, B; Rensing, L; Richter-Landsberg, C; Xu, C, 1994
)
0.29
" No toxicity was observed when cells were exposed to 100 microM Zn- or Fe-EDTA, but the same concentration of Cu-EDTA was as toxic as Na-EDTA."( On the toxicity of low doses of tetrasodium-ethylenediamine-tetraacetate (Na-EDTA) in normal rat kidney (NRK) cells in culture.
Hugenschmidt, S; Planas-Bohne, F; Taylor, DM, 1993
)
0.29
" However, dantrolene dose-dependently blocked the toxicity in the recipient culture, suggesting that the release of intracellular stores of calcium is involved in the toxic effect."( Trauma-induced neurotoxicity in rat hippocampal neurons.
Broder, LD; Brooker, RW; Delisle, RK; Mitchell, HL; Yoon, KW, 1996
)
0.29
" These results suggest that NDPS and its metabolites are not directly toxic to the kidney and are not converted into the ultimate nephrotoxic species by the kidney."( Potential metabolism and cytotoxicity of N-(3,5-dichlorophenyl)succinimide and its hepatic metabolites in isolated rat renal cortical tubule cells.
Harvison, PJ; Henesey, CM, 1995
)
0.29
" This approach may offer a safe alternative to conventional antimicrobial treatment."( Cytotoxic effects of antimicrobial photodynamic therapy on keratinocytes in vitro.
Corry, D; Greenman, J; Purcell, WM; Zeina, B, 2002
)
0.31
"The toxic effects of SnCl2 in K562 cells were analyzed in this study."( Genotoxic effects of stannous chloride (SnCl2) in K562 cell line.
Bernardo-Filho, M; Bezerraa, RJ; Cabral-Neto, JB; Caldeira-de-Araújo, A; Carvalho, JJ; Dantas, FJ; de Mattos, JC; Lage, CA; Leitão, AC; Moraes, MO; Viana, ME, 2002
)
0.31
"Phacoemulsification using trypan blue was safe and effective in managing white cataract and had a high success rate."( Trypan blue as an adjunct for safe phacoemulsification in eyes with white cataract.
Agarwal, A; Agarwal, S; Bagmar, AA; Chowdhary, R; Chowdhary, S; Jacob, S, 2002
)
0.31
"The 3 concentrations of viscoanesthetic solutions appeared to be safe to rabbit corneal endothelium."( Viscoanesthesia. Part I: toxicity to corneal endothelial cells in a rabbit model.
Apple, DJ; Izak, AM; Macky, TA; Pandey, SK; Trivedi, RH; Werner, L, 2003
)
0.32
" Some bacteriocins can be toxic to mammalian cells; therefore, bacteriocins intended for use as biopreservatives must be evaluated for toxicity to mammalian cells and for other toxicities."( In vitro assessment of the cytotoxicity of nisin, pediocin, and selected colicins on simian virus 40-transfected human colon and Vero monkey kidney cells with trypan blue staining viability assays.
Murinda, SE; Rashid, KA; Roberts, RF, 2003
)
0.32
" The potential toxic effects of the spin traps were measured by two estimates of cell viability (trypan blue exclusion and colony formation) and one of cell function (rate of oxygen consumption)."( Spin traps: in vitro toxicity and stability of radical adducts.
Demidenko, E; Joseph, J; Kalyanaraman, B; Khan, N; O'Hara, J; Rosen, GM; Sun, J; Swartz, HM; Wilmot, CM, 2003
)
0.32
" The comparison with other bioassays showed that the SF-9 insect cell line could represent a further tool to screen for the toxic effects of fungal metabolites especially for beauvericin, gliotoxin, and zearalenone."( Cytotoxicity of fungal metabolites to lepidopteran (Spodoptera frugiperda) cell line (SF-9).
Fornelli, F; Logrieco, A; Minervini, F, 2004
)
0.32
"Copper, though essential, is highly toxic when present in excess, as in Wilson disease, a genetic disorder of hepatic copper metabolism."( In vitro assessment of copper-induced toxicity in the human hepatoma line, Hep G2.
Choi, S; Roberts, EA; Sabean, M; Seth, R; Yang, S, 2004
)
0.32
" All five stimulants had a cytotoxic action on the granulocytes and the toxic dose for some of these stimulants was found to be below their commercially prescribed dose."( In vitro cytotoxicity of crustacean immunostimulants for lobster (Homarus gammarus) granulocytes demonstrated using the neutral red uptake assay.
Hauton, C; Smith, VJ, 2004
)
0.32
"The TB was not toxic to the retinal pigment epithelium cell cultures at any concentration or over any period of exposure, whereas ICG dye demonstrated dose-dependent and exposure-dependent toxicity."( Comparison of the in vitro toxicity of indocyanine green to that of trypan blue in human retinal pigment epithelium cell cultures.
Gale, JS; Gonder, JR; Hutnik, CM; Mao, AJ; Proulx, AA, 2004
)
0.32
" Trypan blue is safe in a cell culture model."( Safety testing of indocyanine green and trypan blue using retinal pigment epithelium and glial cell cultures.
Hillenkamp, J; Jackson, TL; Knight, BC; Marshall, J; Stanford, MR; Thomas, D; Zhang, JJ, 2004
)
0.32
" After 48 h of exposure, the MTT and trypan blue dye-exclusion tests indicated that NIV was significantly more toxic than DON, and both were significantly more toxic than FB1."( Cytotoxicity induced by nivalenol, deoxynivalenol, and fumonisin B1 in the SF-9 insect cell line.
Fornelli, F; Minervini, F; Mulè, G,
)
0.13
" But they may have toxic effects on the retina."( Toxic effects of indocyanine green, infracyanine green, and trypan blue on the human retinal pigmented epithelium.
Beby, F; Boehnke, M; Flueckiger, F; Garweg, JG; Halberstadt, M; Kodjikian, L; Richter, T, 2005
)
0.33
"40%, and FS 10% appeared to be safe as determined by no cytotoxic effects on rabbit corneal endothelial cells in culture."( Comparison of dyes for cataract surgery. Part 1: cytotoxicity to corneal endothelial cells in a rabbit model.
Chang, YS; Chen, YT; Hsiao, JH; Tseng, SH; Tseng, SY, 2005
)
0.33
"5% are safe for assisting visualization of the anterior capsule during phacoemulsification of mature cataract."( Safety of trypan blue 1% and indocyanine green 0.5% in assisting visualization of anterior capsule during phacoemulsification in mature cataract.
Chung, CF; Lai, JS; Lam, DS; Liang, CC; Lo, ES, 2005
)
0.33
"Triamcinolone acetonide is toxic to proliferating cells of retinal origin in vitro at doses normally used in clinical practice."( Toxicity of triamcinolone acetonide on retinal neurosensory and pigment epithelial cells.
Kenney, MC; Kuppermann, BD; Mungcal, JK; Narayanan, R; Seigel, GM, 2006
)
0.33
"To determine whether trypan blue (TB) is toxic to cultured human retinal pigment epithelial (ARPE-19) cells, and whether hypothermia can protect ARPE-19 cells against TB toxicity."( Hypothermia protects cultured human retinal pigment epithelial cells against trypan blue toxicity.
Abe, T; Fuse, N; Kunikata, H; Murata, H; Nakagawa, Y; Sagara, Y; Sato, H; Tamai, M; Tomita, H; Wada, Y, 2006
)
0.33
"These results indicate that TB is toxic to human RPE cells, and the toxicity is dose- and exposure duration-dependent."( Hypothermia protects cultured human retinal pigment epithelial cells against trypan blue toxicity.
Abe, T; Fuse, N; Kunikata, H; Murata, H; Nakagawa, Y; Sagara, Y; Sato, H; Tamai, M; Tomita, H; Wada, Y, 2006
)
0.33
" Adverse effects on anterior and posterior segments were evaluated by slit lamp biomicroscopy and ophthalmoscopy."( Administration of novel dyes for intraocular surgery: an in vivo toxicity animal study.
Eibl, K; Freyer, W; Haritoglou, C; Kampik, A; Mankowska, A; May, CA; Rejdak, R; Schuettauf, F; Thaler, S; Zrenner, E, 2006
)
0.33
"BPB or LGSF produced no significantly detectable toxic effects on the retina in vivo."( Administration of novel dyes for intraocular surgery: an in vivo toxicity animal study.
Eibl, K; Freyer, W; Haritoglou, C; Kampik, A; Mankowska, A; May, CA; Rejdak, R; Schuettauf, F; Thaler, S; Zrenner, E, 2006
)
0.33
" Because 1/10 -vTA appeared to be safe for up to 30 minutes of exposure, use of 1/10 dilutions of vehicle-removed TA is suggested to help surgeons visualize prolapsed vitreous during anterior vitrectomy in complicated cataract surgeries."( Triamcinolone acetonide suspension toxicity to corneal endothelial cells.
Chang, YS; Chen, MF; Tseng, SH; Tseng, SY; Wu, CL, 2006
)
0.33
"Moxifloxacin (250 microg/mL) seems to be safe as an additive agent for cornea storage media."( Efficacy and safety of moxifloxacin as an additive in Optisol-GS a preservation medium for corneal donor tissue.
Dahl, P; Hu, DN; Koplin, RS; McCormick, S; Meskin, SW; Ritterband, DC; Seedor, JA; Shah, MK; Shao, S; Shapiro, DE, 2006
)
0.33
"To test in vitro whether gadolinium-based contrast agents induce fewer toxic effects on renal tubular cells than does an iodinated contrast medium at concentrations used for angiography."( Cytotoxicity of iodinated and gadolinium-based contrast agents in renal tubular cells at angiographic concentrations: in vitro study.
Grgic, A; Heckmann, MB; Heinrich, MC; Kohlbacher, S; Kuhlmann, MK; Scheer, M; Uder, M, 2007
)
0.34
" We synthesized and purified DONGLU and tested its immunotoxicity, hypothesizing that DONGLU would be much less toxic to K562 cells compared with DON."( Synthesis and characterization of deoxynivalenol glucuronide: its comparative immunotoxicity with deoxynivalenol.
Cunnick, J; Hendrich, S; Murphy, P; Wu, X, 2007
)
0.34
"To investigate the toxic effects of triamcinolone acetonide (TA) suspensions on human retinal pigment epithelial (RPE) cells."( Cytotoxicity of triamcinolone acetonide on human retinal pigment epithelial cells.
Chang, YS; Kuo, PY; Tseng, SH; Tseng, SY; Wu, CL, 2007
)
0.34
"0mg/mL, the concentration in commercial TA suspensions, was toxic within 5min on each assay for both human and rabbit RPE cells."( In vitro benzyl alcohol cytotoxicity: implications for intravitreal use of triamcinolone acetonide.
Chang, YS; Kuo, PY; Tseng, SH; Tseng, SY; Wu, CL, 2008
)
0.35
"MSICS with trypan blue staining of the anterior capsule is a safe and effective method of cataract extraction for patients with BBC."( Safety and efficacy of manual small incision cataract surgery for brunescent and black cataracts.
Krishnan, KT; Ravindran, RD; Singh, GP; Tan, CS; Veena, K; Venkatesh, R, 2009
)
0.35
"All dyes demonstrated relatively safe viability profiles in both cell lines at surgically relevant concentrations and times."( Comparison of the in vitro safety of intraocular dyes using two retinal cell lines: a focus on brilliant blue G and indocyanine green.
Gonder, J; Hutnik, C; Liu, H; Proulx, A; Yuen, D, 2009
)
0.35
" For the released element concentrations the lowest percentage of viable cells (mean+/-SD) was evident with Zn, Cu or Ni indicating that they are the highly toxic elements."( In vitro cytotoxicity evaluation of elemental ions released from different prosthodontic materials.
Elshahawy, WM; Kramer, P; Watanabe, I, 2009
)
0.35
" The highest body burden has been found in toddlers and infants, due to their exposure through breast milk and house dust, and the current concern for potential adverse health effects of PBDEs relates to their developmental neurotoxicity."( Low concentrations of the brominated flame retardants BDE-47 and BDE-99 induce synergistic oxidative stress-mediated neurotoxicity in human neuroblastoma cells.
Alinovi, R; Caglieri, A; Costa, LG; Giordano, G; Goldoni, M; Mutti, A; Pellacani, C; Pinelli, S; Poli, D; Tagliaferri, S, 2010
)
0.36
" In conclusion, deferoxamine is directly toxic on RPE cells, its toxicity depending on p38."( Deferoxamine mesylate is toxic for retinal pigment epithelium cells in vitro, and its toxicity is mediated by p38.
Herdegen, T; Klettner, A; Koinzer, S; Roider, J; Waetzig, V, 2010
)
0.36
"To report the inadvertent subretinal migration and effect of trypan blue (TB) during staining of the epiretinal membrane (ERM) for macular pucker, and internal limiting membrane during macular hole (MH) surgery, and to suggest alternative safe methods of injecting TB."( Subretinal migration of trypan blue during macular hole and epiretinal membrane peel: an observational case series. Is there a safer method?
El Ghrably, I; Ghosh, S; Issa, S; Stannard, K, 2010
)
0.36
"Ecasol present as a residual disinfectant in DUWL output water is very unlikely to have adverse effects on human oral tissues at levels effective in maintaining DUWL output water quality at better than potable standard water quality."( Lack of cytotoxicity by Trustwater Ecasol™ used to maintain good quality dental unit waterline output water in keratinocyte monolayer and reconstituted human oral epithelial tissue models.
Boyle, MA; Coleman, DC; O'Donnell, MJ; Russell, RJ, 2010
)
0.36
"Carbon nanotubes (CNT) possess beneficial physicochemical and mechanical properties; however, despite these advantages there are concerns regarding the adverse effects of CNT on lung and development of diseases, such as lung cancer and mesothelioma."( Determination of cytotoxicity attributed to multiwall carbon nanotubes (MWCNT) in normal human embryonic lung cell (WI-38) line.
Joo, HJ; Kim, JS; Lee, JH; Song, KS; Yu, IJ, 2010
)
0.36
"These results indicate that both air and SF6 injected into the anterior chamber of the eye can induce intraocular reaction in the feline model and that SF6 is more toxic than air in terms of endothelial cell loss and anterior chamber inflammation."( Corneal endothelial toxicity of air and SF6.
Aminian, A; Bensaoula, T; Brunette, I; Carrier, P; Germain, L; Hoffart, L; Landry, H; Nada, O; Proulx, S, 2011
)
0.37
" Methanol and ethanol were the least toxic cryoprotectants tested."( Studies on cryoprotectant toxicity to zebrafish (Danio rerio) ovarian tissue fragments.
Anil, S; Ghafari, F; Rawson, DM; Zampolla, T; Zhang, T,
)
0.13
"Bevacizumab was safe and not toxic to BCE cells at concentrations commonly used in clinical practice."( Evaluation of cytotoxicity of bevacizumab on VEGF-enriched corneal endothelial cells.
Chalam, KV; Rusovici, R; Sakhalkar, M, 2011
)
0.37
"5, proved to be remarkably toxic to RPE cells with or without trypan blue."( Effects of light exposure, pH, osmolarity, and solvent on the retinal pigment epithelial toxicity of vital dyes.
Barros, NM; Carmona, AK; Coppini, LP; Costa, EF; Dib, E; Farah, ME; Lima Filho, AA; Magalhães, O; Maia, M; Moraes-Filho, MN; Neves, RL; Penha, FM; Rodrigues, EB, 2013
)
0.39
"DiI is a convenient method for ASCs labeling which causes no toxic effects and does not impair the proliferation, migration or differentiation potential of ASCs after the labeling procedure."( DiI labeling of human adipose-derived stem cells: evaluation of DNA damage, toxicity and functional impairment.
Froelich, K; Hackenberg, S; Hagen, R; Kleinsasser, N; Radeloff, A; Ramos Tirado, M; Scherzed, A; Schmidt, K; Steussloff, G; Technau, A, 2013
)
0.39
"Combinations of trypan blue (TB), Brilliant Blue G (BBG) and polyethyleneglycol had been shown before to be less toxic to ARPE retinal pigment epithelial cells than TB alone."( Brilliant Blue G as protective agent against trypan blue toxicity in human retinal pigment epithelial cells in vitro.
Awad, D; Bartok, M; Gabel, D; Mohr, A; Schrader, I; Sudumbrekar, N, 2013
)
0.39
"075 % and higher was toxic to the cells already after 30 min incubation."( Brilliant Blue G as protective agent against trypan blue toxicity in human retinal pigment epithelial cells in vitro.
Awad, D; Bartok, M; Gabel, D; Mohr, A; Schrader, I; Sudumbrekar, N, 2013
)
0.39
" Phytotoxicity study revealed the less toxic nature of the metabolites compared to the dye."( Biotransformation of Direct Blue 1 by a moderately halophilic bacterium Marinobacter sp. strain HBRA and toxicity assessment of degraded metabolites.
Arun Prasad, AS; Bhaskara Rao, KV; Satyanarayana, VS, 2013
)
0.39
"L/Z-based dye solutions demonstrated a safe profile in in vitro and in vivo models, and may be a useful tool for staining intraocular structures."( Dye solutions based on lutein and zeaxanthin: in vitro and in vivo analysis of ocular toxicity profiles.
Badaró, E; Belfort, R; Casaroli-Marano, RP; Lima-Filho, AA; Maia, M; Martínez-Conesa, EM; Nunes, RP; Rodrigues, EB; Sousa-Martins, D, 2015
)
0.42
"The present study showed that intracameral TB injection is safe systematically but may be toxic to corneal tissue, as demonstrated using oxidative stress parameters and histopathological evaluation."( Evaluation of the safety of intracameral trypan blue injection on corneal tissue using oxidative stress parameters and apoptotic activity: an experimental study.
Adibelli, MF; Akal, A; Demir, T; Dusunur, M; Goncu, T; Guldur, ME; Guler, M; Kocarslan, S; Ozkan, U; Ulas, T,
)
0.13
" To prevent adverse side effects of drugs, it is important to investigate potential toxicity in vitro."( ATP-based cell viability assay is superior to trypan blue exclusion and XTT assay in measuring cytotoxicity of anticancer drugs Taxol and Imatinib, and proteasome inhibitor MG-132 on human hepatoma cell line HepG2.
Kammerer, S; Küpper, JH; Nowak, E, 2018
)
0.48
"04% TB is relatively safe and effective for subretinal staining."( Safety evaluation of subretinal injection of trypan blue in rats.
Chen, DF; Chen, JY; Fang, Y; Niu, LL; Sun, XH; Thee, EF; Wu, JH; Yao, XQ, 2018
)
0.48
"Selective laser capsulotomy using a new proprietary trypan blue formulation was safe and effective in cataract surgery."( Efficacy and safety of a new selective laser device to create anterior capsulotomies in cataract patients.
Mordaunt, D; Packard, R; Stodulka, P, 2019
)
0.51
" However, considering a wide variation in the effects of busulfan among animal species, its dosage and route of infusion need optimization to prepare effective and safe recipients."( Establishment of effective and safe recipient preparation for germ-cell transplantation with intra-testicular busulfan treatment in pre-pubertal Barbari goats.
Chauhan, MS; Kharche, SD; Pathak, M; Pawaiya, RVS; Quadri, SA; Singh, MK; Singh, SP; Soni, YK, 2022
)
0.72
"The toxic effects of four cationic porphyrins on various human cells were studied in vitro."( Mechanisms of Phototoxic Effects of Cationic Porphyrins on Human Cells In Vitro.
Chashchina, GV; Egorov, AE; Kaluzhny, DN; Pan, X; Popov, KV; Tevonyan, LL; Vishnyakova, KS; Yegorov, YE, 2023
)
0.91

Pharmacokinetics

ExcerptReferenceRelevance
" Pharmacokinetic analyses of concentrations of trypan blue in serum resulted in fitting a two-compartment open model, with first order absorption, for both strains."( Comparative pharmacokinetics of trypan blue in female Sprague-Dawley and Long-Evans rats.
Frakes, RA; Sharma, RP; Taylor, MJ; Willhite, CC, 1984
)
0.27

Compound-Compound Interactions

ExcerptReferenceRelevance
" In combination with life-dead assays, the proliferation can be correlated to the survival rate of the encapsulated cells."( MTS colorimetric assay in combination with a live-dead assay for testing encapsulated L929 fibroblasts in alginate poly-L-lysine microcapsules in vitro.
Bünger, CM; de Vos, P; Hopt, UT; Jahnke, A; Stange, J, 2002
)
0.31
"We investigated the toxic effect of indole-3-acetic acid (IAA) combined with horseradish peroxidase (HRP) on Prototheca zopfii from bovine mastitis."( Microbicidal action of indole-3-acetic acid combined with horseradish peroxidase on Prototheca zopfii from bovine mastitis.
Costa, EJ; Cunha, LT; De Melo, MP; Pugine, SM; Silva, MR, 2010
)
0.36
"To demonstrate canalogram patterns observed when trypan blue tracer is combined with oculoviscoelastic device during ab interno canaloplasty, and discuss surgical results and potential implications for diagnosis, prognosis, and treatment."( Ab Interno Canaloplasty in Open-angle Glaucoma Patients Combined With In Vivo Trypan Blue Aqueous Venography.
Ahmed, IIK; Crichton, A; Docherty, G; Ford, B; Gooi, P; Schlenker, M; Waldner, D, 2020
)
0.56

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
" It was established that in acute peritonitis the rate of absorption of the colloid dye (tryptan blue) was sharply decreased."( [Effect of kallikrein and its inhibitor on absorption from the abdominal cavity in peritonitis].
Levitskiĭ, AP; Synovets, AS; Zubkov, OB, 1982
)
0.26

Dosage Studied

Trypan blue potentiated the effect of histamine and shifted its dose-response curve to the left. It did not affect the contractile effects of acetylcholine. azure A staining discriminates degranulated from non-degranulated mast cells.

ExcerptRelevanceReference
" The dose-response relationship was similar to that obtained with intact tissue."( Preparation of single smooth muscle cells from guinea pig taenia coli by combinations of purified collagenase and papain.
Kobayashi, M; Maruyama, I; Momose, K; Oyamada, H; Yoshida, C, 1987
)
0.27
" The above-mentioned cytostatic and cytotoxic effects of CP-46,665 were dependent on dosage and incubation time."( Cytotoxicity of the alkyl-linked lipoidal amine 4-aminomethyl-1-[2,3-(di-n-decyloxy)-n-propyl]-4-phenylpiperidine (CP-46,665) in cells from human tumors and leukemias.
Berdel, WE; Fink, U; Rastetter, J; Reichert, A; Schick, HD; Ulm, K, 1985
)
0.27
" As the dosage increased to 50,000 rad, chemotaxis decreased to approximately 50% of nonirradiated control values."( Effect of high doses of radiation on human neutrophil chemotaxis, phagocytosis and morphology.
Anderson, RE; Harvey, RL; Holley, TR; Van Epps, DE; Williams, RC, 1974
)
0.25
" The resulting dose-response curves have been compared with each another."( A comparative study of the inhibitory effect of trypan blue on mouse erythrocyte and C3 binding receptors of peripheral blood mononuclear cells from healthy donors and patients suffering from chronic lymphocytic leukaemia.
Boda, K; Dobozy, A; Hunyadi, J; Kenderessy, AS; Krizsa, F; Simon, N, 1983
)
0.27
" A dose-response for degranulation by compound 48/80 was performed and it was shown that azure A staining (in 40% sucrose) discriminates degranulated from non-degranulated mast cells, while trypan blue staining discriminates between cytotoxic and non-cytotoxic degranulation."( Determination of rat mast cells by flow-cytometry.
De Weck, AL; Nakagawa, T; Stadler, BM, 1980
)
0.26
" A dose-response inhibition was demonstrated with maximum inhibition observed at 3 hr of exposure."( Gap junction-mediated intercellular communication in primary cultures of rainbow trout hepatocytes.
Baldwin, LA; Calabrese, EJ, 1994
)
0.29
" While trypan blue potentiated the effect of histamine and shifted its dose-response curve to the left, it did not affect the contractile effects of acetylcholine."( Effect of trypan blue on the action of acetylcholine, histamine and salbutamol in the isolated guinea-pig ileum.
Damankeshideh, M; Mahmoudian, M, 1996
)
0.29
"), the dose-response curve of dye leakage against the challenge dose of lipopolysaccharide shifted about 2-fold to the higher dose."( Tolerance to lipopolysaccharide-induced increase in vascular permeability in mouse skin.
Fujii, E; Irie, K; Muraki, T; Ogawa, A; Ohba, K; Tsukahara, F; Uchida, Y, 1996
)
0.29
"An obvious dose-response relationship for the antiproliferative effects of each drug was detected."( Comparison of the in vitro antiproliferative effects of five immunosuppressive drugs on lymphocytes in whole blood from cats.
Craigmill, AL; Gregory, CR; Kyles, AE, 2000
)
0.31
" An important loss of viability induced by SnCl2 in a dose-response manner was observed in cells treated in Tris-buffered saline (TBS)."( Genotoxic effects of stannous chloride (SnCl2) in K562 cell line.
Bernardo-Filho, M; Bezerraa, RJ; Cabral-Neto, JB; Caldeira-de-Araújo, A; Carvalho, JJ; Dantas, FJ; de Mattos, JC; Lage, CA; Leitão, AC; Moraes, MO; Viana, ME, 2002
)
0.31
" This method could prove useful in assessing adherence to product dosing in future microbicide trials."( Assessment of adherence to product dosing in a pilot microbicide study.
Herold, BC; Hogarty, K; Kasowitz, A; Keller, MJ, 2007
)
0.34
" Cells were exposed to an ozone-saturated physiological solution using various dosing regimens, including acute exposure and various repetitive exposures."( Studies on cellular resilience and adaptation following acute and repetitive exposure to ozone in cultured human epithelial (HeLa) cells.
Brink, CB; Oliver, DW; Pretorius, A; van Niekerk, BP; Venter, DP, 2008
)
0.35
" In addition, when the cells were treated with exogenous and endogenous oxidative stressors, MTT reduction was shown to be sensitive to a shift to a more oxidizing cellular environment within a narrow range without loss of membrane integrity, and this effect increased in a linear fashion, dependent on the dosage of cytosolic extracts containing various physiological reductants, small reductive molecules (NADPH and GSH), and artificial DTT reducing agent."( Discriminative cytotoxicity assessment based on various cellular damages.
Jeong, D; Kim, H; Lee, TY; Yoon, SC, 2009
)
0.35
" Variables investigated included cell concentration, time in culture, dosing regimens (a 13 day and a truncated 8 day protocol) and the impact of restimulation in vitro with T cell mitogens."( Cytokine profiling of chemical allergens in mice: impact of mitogen on selectivity of response.
Betts, CJ; Caddick, HT; Dearman, RJ; Kimber, I, 2009
)
0.35
" We compared the dose-response of both strains to permethrin in a forced-contact filter paper bioassay."( Innovative sugar-insecticide feeding bioassay for adult female Anopheles gambiae (Diptera: Culicidae).
Apperson, CS; Arellano, C; Roe, RM; Stell, FM, 2013
)
0.39
" However, when both nano- and large-size forms of TiO2 were evaluated with the comet assay in Drosophila hemocytes, a significant increase in DNA damage, with a direct dose-response pattern, was observed for TiO2 NPs."( Genotoxic testing of titanium dioxide anatase nanoparticles using the wing-spot test and the comet assay in Drosophila.
Carmona, ER; Escobar, B; Marcos, R; Vales, G, 2015
)
0.42
"Release test methods for topical dosage forms including pharmacopeial tests require a large volume of release media, with limited application for high throughput screening."( Revisiting in vitro release test for topical gel formulations: The effect of osmotic pressure explored for better bio-relevance.
Chung, S; Jeong, S; Kim, A, 2018
)
0.48
" Dead cells can be a safety concern for the patient, and dosing is often based on the number of living cells which are the active ingredient of the drug product."( Establishing a reference focal plane using beads for trypan-blue-based viability measurements.
Chalfoun, J; Chan, LL; Elliott, J; Halter, M; Kurbanov, F; Lund, SP; Peskin, A; Pierce, L; Sarkar, S, 2021
)
0.62
" However, considering a wide variation in the effects of busulfan among animal species, its dosage and route of infusion need optimization to prepare effective and safe recipients."( Establishment of effective and safe recipient preparation for germ-cell transplantation with intra-testicular busulfan treatment in pre-pubertal Barbari goats.
Chauhan, MS; Kharche, SD; Pathak, M; Pawaiya, RVS; Quadri, SA; Singh, MK; Singh, SP; Soni, YK, 2022
)
0.72
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (13)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
TDP1 proteinHomo sapiens (human)Potency9.44110.000811.382244.6684AID686978; AID686979
AR proteinHomo sapiens (human)Potency6.31760.000221.22318,912.5098AID743035; AID743042; AID743054; AID743063
estrogen nuclear receptor alphaHomo sapiens (human)Potency16.09930.000229.305416,493.5996AID743075; AID743079; AID743080; AID743091
aryl hydrocarbon receptorHomo sapiens (human)Potency11.88320.000723.06741,258.9301AID743122
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency11.88320.001723.839378.1014AID743083
nuclear receptor subfamily 1, group I, member 2Rattus norvegicus (Norway rat)Potency22.38720.10009.191631.6228AID1346983
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency12.35720.000323.4451159.6830AID743065; AID743067
Cellular tumor antigen p53Homo sapiens (human)Potency33.49150.002319.595674.0614AID651631
ATPase family AAA domain-containing protein 5Homo sapiens (human)Potency16.78550.011917.942071.5630AID651632
Ataxin-2Homo sapiens (human)Potency16.78550.011912.222168.7989AID651632
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Tyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)IC50 (µMol)3.90000.00053.49849.7600AID157217
Tyrosine-protein phosphatase 1Saccharomyces cerevisiae S288CIC50 (µMol)7.40001.20004.30007.4000AID220230
P2Y purinoceptor 2Homo sapiens (human)IC50 (µMol)171.00005.61005.71005.8100AID150322
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (175)

Processvia Protein(s)Taxonomy
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
positive regulation of JUN kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein dephosphorylationTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
insulin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of signal transductionTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of signal transductionTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
actin cytoskeleton organizationTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of endocytosisTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of vascular endothelial growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endoplasmic reticulum unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of intracellular protein transportTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cellular response to unfolded proteinTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
peptidyl-tyrosine dephosphorylationTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
platelet-derived growth factor receptor-beta signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
IRE1-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
insulin receptor recyclingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of MAP kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of insulin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of type I interferon-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
growth hormone receptor signaling pathway via JAK-STATTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of protein tyrosine kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of ERK1 and ERK2 cascadeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of hepatocyte growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of IRE1-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of PERK-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of receptor catabolic processTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
intracellular monoatomic ion homeostasisP2Y purinoceptor 2Homo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayP2Y purinoceptor 2Homo sapiens (human)
G protein-coupled purinergic nucleotide receptor signaling pathwayP2Y purinoceptor 2Homo sapiens (human)
positive regulation of mucus secretionP2Y purinoceptor 2Homo sapiens (human)
cellular response to ATPP2Y purinoceptor 2Homo sapiens (human)
blood vessel diameter maintenanceP2Y purinoceptor 2Homo sapiens (human)
G protein-coupled receptor signaling pathwayP2Y purinoceptor 2Homo sapiens (human)
cell population proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of B cell proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
nuclear DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
signal transduction in response to DNA damageATPase family AAA domain-containing protein 5Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
isotype switchingATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of isotype switching to IgG isotypesATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloadingATPase family AAA domain-containing protein 5Homo sapiens (human)
regulation of mitotic cell cycle phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of cell cycle G2/M phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of receptor internalizationAtaxin-2Homo sapiens (human)
regulation of translationAtaxin-2Homo sapiens (human)
RNA metabolic processAtaxin-2Homo sapiens (human)
P-body assemblyAtaxin-2Homo sapiens (human)
stress granule assemblyAtaxin-2Homo sapiens (human)
RNA transportAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (50)

Processvia Protein(s)Taxonomy
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
RNA bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
insulin receptor bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
zinc ion bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
enzyme bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein kinase bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
receptor tyrosine kinase bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cadherin bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
ephrin receptor bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein phosphatase 2A bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
non-membrane spanning protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein bindingP2Y purinoceptor 2Homo sapiens (human)
signaling receptor activityP2Y purinoceptor 2Homo sapiens (human)
G protein-coupled purinergic nucleotide receptor activityP2Y purinoceptor 2Homo sapiens (human)
A1 adenosine receptor bindingP2Y purinoceptor 2Homo sapiens (human)
G protein-coupled UTP receptor activityP2Y purinoceptor 2Homo sapiens (human)
protein bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP hydrolysis activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloader activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
RNA bindingAtaxin-2Homo sapiens (human)
epidermal growth factor receptor bindingAtaxin-2Homo sapiens (human)
protein bindingAtaxin-2Homo sapiens (human)
mRNA bindingAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (32)

Processvia Protein(s)Taxonomy
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
plasma membraneTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
mitochondrial matrixTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
early endosomeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endoplasmic reticulumTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytosolTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
mitochondrial cristaTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endosome lumenTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
sorting endosomeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmic side of endoplasmic reticulum membraneTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein-containing complexTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endoplasmic reticulumTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
early endosomeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
plasma membraneP2Y purinoceptor 2Homo sapiens (human)
plasma membraneP2Y purinoceptor 2Homo sapiens (human)
Elg1 RFC-like complexATPase family AAA domain-containing protein 5Homo sapiens (human)
nucleusATPase family AAA domain-containing protein 5Homo sapiens (human)
cytoplasmAtaxin-2Homo sapiens (human)
Golgi apparatusAtaxin-2Homo sapiens (human)
trans-Golgi networkAtaxin-2Homo sapiens (human)
cytosolAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
membraneAtaxin-2Homo sapiens (human)
perinuclear region of cytoplasmAtaxin-2Homo sapiens (human)
ribonucleoprotein complexAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (16)

Assay IDTitleYearJournalArticle
AID157217Inhibition of human PTPase 1B2004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Evans Blue and other dyes as protein tyrosine phosphatase inhibitors.
AID99424Inhibition of human Leukocyte Antigen Related(LAR) protein tyrosine phosphatase D12004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Evans Blue and other dyes as protein tyrosine phosphatase inhibitors.
AID1126825Competitive inhibition of rat brain VGLUT assessed as inhibition of [3H]glutamate uptake into vesicles after 10 mins by scintillation spectrophotometry2014European journal of medicinal chemistry, May-06, Volume: 78Design, synthesis and biological evaluation of small-azo-dyes as potent Vesicular Glutamate Transporters inhibitors.
AID152473The compound was evaluated for antagonist activity against P2X purinoceptor2002Journal of medicinal chemistry, Sep-12, Volume: 45, Issue:19
Purine and pyrimidine (P2) receptors as drug targets.
AID475923Inhibition of VGLUT2010Bioorganic & medicinal chemistry letters, Apr-15, Volume: 20, Issue:8
Conformationally-restricted amino acid analogues bearing a distal sulfonic acid show selective inhibition of system x(c)(-) over the vesicular glutamate transporter.
AID381200Cell viability of Wistar rat peritoneal leukocytes by trypan blue exclusion method1999Journal of natural products, Sep, Volume: 62, Issue:9
Novel and known constituents from Buddleja species and their activity against leukocyte eicosanoid generation.
AID588212Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID1069335Inhibition of VGLUT (unknown origin)2014Bioorganic & medicinal chemistry letters, Feb-01, Volume: 24, Issue:3
The development of benzo- and naphtho-fused quinoline-2,4-dicarboxylic acids as vesicular glutamate transporter (VGLUT) inhibitors reveals a possible role for neuroactive steroids.
AID150322The compound was evaluated for antagonistic activity against P2Y purinoceptor 2 (P2Y2)2002Journal of medicinal chemistry, Sep-12, Volume: 45, Issue:19
Purine and pyrimidine (P2) receptors as drug targets.
AID588211Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID220230Inhibitory activity against Saccharomyces cerevisiae Tyrosine phosphatase 12004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Evans Blue and other dyes as protein tyrosine phosphatase inhibitors.
AID588213Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID1126820Inhibition of rat brain VGLUT assessed as inhibition of [3H]glutamate uptake into vesicles after 10 mins by scintillation spectrophotometry2014European journal of medicinal chemistry, May-06, Volume: 78Design, synthesis and biological evaluation of small-azo-dyes as potent Vesicular Glutamate Transporters inhibitors.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (2,682)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901151 (42.92)18.7374
1990's366 (13.65)18.2507
2000's683 (25.47)29.6817
2010's400 (14.91)24.3611
2020's82 (3.06)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 76.61

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index76.61 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.92 (4.65)
Search Engine Demand Index127.33 (26.88)
Search Engine Supply Index2.01 (0.95)

This Compound (76.61)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Trials40 (1.40%)5.53%
Reviews1 (11.11%)6.00%
Reviews37 (1.30%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies48 (1.68%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other8 (88.89%)84.16%
Other2,732 (95.62%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]